PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
1 clinical trials · Condition
◉ Watch PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer (NCT04997993) | Deborah Doroshow | 2023-12-13 |
Track PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.